Popular Articles
Grapefruit Benefits

Children's Hospitals And Clinics Of Minnesota Receive Level III Trauma Designation
The Minnesota Department of Health recently designated Children"s Hospitals and Clinics of Minnesota"s two hospital locations as Level III Trauma Hospitals. Children"s of Minnesota has the sixth busiest pediatric emergency department in the nation with over 84,000 visits per year, and already treats around 450 trauma cases each year. Children"s voluntarily participated in the intense designation process, which included an external review of the hospitals" res and capabilities to care for young trauma patients. Children"s met the required standards of commitment, clinical and equipment res, and staff training.
generic viagra online
A Vaccine For Ear Infections - Without The Needle
Even when she"s well, little Cammy Barber doesn"t like getting her ears
News of the day
Boston Globe Examines Hospital's Attempt To Reduce Emergency Department Visits, Hospital Stays Among Elderly
Efforts by Massachusetts General Hospital to reduce health spending could be indicative of the difficulty the health industry faces in trying to reduce spending growth, the Boston Globe reports. Industry groups last week pledged to seek a 1.5% overall reduction in health care spending over the next 10 years.Massachusetts General"s program, which began in 2006, aims to reduce hospitalizations among the elderly by 15% to 20%, as well as to improve the quality of care the elderly receive. A study looking at 35 efforts to improve elderly care found that only six, including Massachusetts General"s program, saved money or covered their costs, the Globe reports. Massachusetts General"s program relies on nurses in primary care practices to be in regular contact with patients and provide assistance with nonmedical services. The program also uses electronic health records to coordinate care. The hospital spent $8 million to $9 million over the first three years of the program to provide enhanced services to patients. Hospital readmissions fell by 19%, admissions decreased by 17% and ED visits dropped by 15% between 2007 and 2008, according to preliminary research. The program saved enough by reducing hospital admissions and emergency department visits to cover its costs and also to generate savings of $7 million to $10 million. The overall cost for the program was about 5% less than for a group of other patients treated in a more traditional way.According to Harvard University health care economist David Cutler, improving care and reducing costs among the elderly is a necessary component of health reform. He said, "If we can"t do this, it doesn"t bode well for health reform." Eric Weil, a primary care physician and medical director of the program at Massachusetts General, said, "Medicare is looking for any and every way to save money," adding, "This is a population of patients who are sick and will get sicker over time. Any opportunity to demonstrate savings in this group of patients is good, and 5% is very good" (Kowalczyk, Boston Globe, 5/17).
Endocrinology

Varian Medical Systems Introduces Fast And Precise Brachytherapy Planning System At GEC-ESTRO In Portugal

A significantly more accurate* way of calculating the dosimetry of cancer treatments will be introduced by Varian Medical Systems (NYSE: VAR) at the GEC-ESTRO exhibition in Porto, Portgual, on May 14-16. BrachyVision™ Acuros™ enables clinicians to rapidly calculate patient doses for brachytherapy treatments (a form of radiotherapy) with an extremely high level of accuracy. "This is a quantum leap forward in terms of accuracy with timeframes that were previously thought unimaginable," says Sophie Wetherall, Varian BrachyTherapy software product manager. "BrachyVision Acuros offers an improvement in dose calculation that will help clinicians make better decisions about dose to their patients and further their knowledge to make treatments more accurate." Dose levels for brachytherapy have generally been calculated as if the s are surrounded by water, whereas in reality a patient"s anatomy contains many different materials such as bone, lung, tissue and air, as well as additional materials that are often present from inserted applicators. In the past the only way to account for this was using Monte Carlo calculation techniques, something that was only available as a research tool. Now, for the first time in routine clinical brachytherapy, BrachyVision Acuros is able to account for the dose effects from these variations. "BrachyVision Acuros calculation times tend to average between three and eight minutes depending on the applicator used," adds Sophie Wetherall. "By comparison, the same calculations could take hours or days using the standard Monte Carlo method." Acuros, developed by Transpire, Inc., is an optimized, radiotherapy-specific rewrite of the software product Attila®, and Varian is working exclusively with Transpire to bring the benefits of this fast and precise calculation method to the radiation oncology field. In so doing, Varian becomes the only brachytherapy supplier with this capability in a commercially available product. BrachyVision Acuros, which uses a technique best described as a "Grid-Based Boltzmann Solver" (GBBS), is the most significant additional feature of Varian"s latest brachytherapy treatment planning software offering, BrachyVision 8.8. The full system will be demonstrated for the first time at GEC-ESTRO. "We are thrilled to be partnering with Varian Medical Systems in introducing the Acuros technology to the clinic," says Gregory Failla, chief executive officer of Transpire, Inc. "Varian"s leading position in the worldwide radiation oncology market ensures that the maximum number of patients will benefit from the improved treatment quality made possible by BrachyVision Acuros." Todd Wareing, Transpire"s chief technology officer, adds, "The release of BrachyVision Acuros marks the culmination of decades of research, first at Los Alamos National Laboratory and then at Transpire, in the development of rapid and accurate alternatives to traditional Monte Carlo based methods." Brachytherapy is a very well established form of radiotherapy which is used routinely to treat a wide range of cancers, including gynaecological, prostate, head & neck, skin and lung. It is often delivered in combination with external beam radiotherapy. * Compared to standard techniques using the American Association of Physicists in Medicine TG43 formulism. NOTE: The BrachyVision™ Acuros™ brachytherapy planning system is not available for sale in the U.S. at this time. About Transpire, Inc. Transpire, Inc., headquartered in Gig Harbor, WA, specializes in the development and application of software for accurately predicting the macroscopic behaviour of radiation. Transpire"s Attila® software is being used worldwide by engineers and scientists for a diverse range of applications including homeland security, fusion research, radiological safety, shielding design, medical physics, and reactor analysis. Transpire is a spin-off from Los Alamos National Laboratory, and in 2008 the Company"s co-founders were recipients of the prestigious Federal Laboratory Consortium award for Excellence in Technology Transfer. Transpire has an ISO-9001:2000 certified quality management system. http://www.transpireinc.com. Varian Medical Systems


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):